Natalizumab Therapy Modulates miR-155, miR-26a and Proinflammatory Cytokine Expression in MS Patients

Open Access

Peer-reviewed

Research Article

Giuseppe Mameli,

Affiliation Department of Medical Sciences, University of Sassari, Sassari, Italy
⨯
Giannina Arru,

Affiliation Department of Experimental Medicine, University of Sassari, Sassari, Italy
⨯
Elisa Caggiu,

Affiliation Department of Medical Sciences, University of Sassari, Sassari, Italy
⨯
Magdalena Niegowska,

Affiliation Department of Medical Sciences, University of Sassari, Sassari, Italy
⨯
Stefania Leoni,

Affiliation Department of Experimental Medicine, University of Sassari, Sassari, Italy
⨯
Giordano Madeddu,

Affiliation Department of Experimental Medicine, University of Sassari, Sassari, Italy
⨯
Sergio Babudieri,

Affiliation Department of Experimental Medicine, University of Sassari, Sassari, Italy
⨯
Gian Pietro Sechi,

Affiliation Department of Experimental Medicine, University of Sassari, Sassari, Italy
⨯
Leonardo A. Sechi

* E-mail: sechila@uniss.it

Affiliation Department of Medical Sciences, University of Sassari, Sassari, Italy
⨯

Reader Comments (0)

Multiple sclerosis
Is the Subject Area "Multiple sclerosis" applicable to this article?

Thanks for your feedback.
MicroRNAs
Is the Subject Area "MicroRNAs" applicable to this article?

Thanks for your feedback.
Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.
Cytokine therapy
Is the Subject Area "Cytokine therapy" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Enzyme-linked immunoassays
Is the Subject Area "Enzyme-linked immunoassays" applicable to this article?

Thanks for your feedback.
Immune response
Is the Subject Area "Immune response" applicable to this article?

Thanks for your feedback.
Polymerase chain reaction
Is the Subject Area "Polymerase chain reaction" applicable to this article?

Thanks for your feedback.